Fifth Third Bancorp’s BeOne Medicines Ltd ONC Stock Holding History

Fifth Third Bancorp’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.42K	Hold	25	–	–	﹤0.01%	3768
2025 Q4	$7.59K	Hold	25	–	–	﹤0.01%	2213
2025 Q3	$8.52K	Buy	+25	New	+$7.59K	﹤0.01%	2196
2023 Q2	–	Sell	-5	Closed	-$1.08K	–	2788
2023 Q1	$1.08K	Buy	+5	New	+$1.2K	﹤0.01%	2634
2022 Q4	–	Sell	-6	Closed	-$1K	–	2771
2022 Q3	$1K	Buy	6 +3	+100%	+$515	﹤0.01%	2611
2022 Q2	$0	Buy	+3	New	+$469	﹤0.01%	2815
2019 Q4	–	Sell	-20	Closed	-$2K	–	2360
2019 Q3	$2K	Buy	20 +17	+567%	+$2.26K	﹤0.01%	2076
2019 Q2	$0	Buy	+3	New	+$381	﹤0.01%	2376

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fifth Third Bancorp's ONC Position: Q1 2026 in Review

Fifth Third Bancorp held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 25 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #3768.

Fifth Third Bancorp first reported a position in ONC in Q2 2019 and has held it in 8 quarters since. The position peaked at $8.52K in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Fifth Third Bancorp held 25 shares of BeOne Medicines Ltd worth $7.42K as of Q1 2026.
Fifth Third Bancorp left its BeOne Medicines Ltd share count unchanged in Q1 2026.
BeOne Medicines Ltd made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3768 holding.
Fifth Third Bancorp first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 8 quarters since.
Fifth Third Bancorp's BeOne Medicines Ltd position peaked at $8.52K in Q3 2025.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.